These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37075191)

  • 1. Vitiligo.
    Okoro U; Usatine RP; Heath CR
    Cutis; 2023 Feb; 111(2):106-107. PubMed ID: 37075191
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo.
    LeWitt TM; Kundu RV
    JAMA Dermatol; 2021 Sep; 157(9):1136. PubMed ID: 34287629
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitiligo effectively treated with electrocautery needling technique.
    Yang L; Wong PM; Yang L; Katayama I; Wu H; Zhang H
    Dermatol Ther; 2020 Nov; 33(6):e14154. PubMed ID: 32767488
    [No Abstract]   [Full Text] [Related]  

  • 4. British Association of Dermatologists guidelines for the management of people with vitiligo 2021.
    Eleftheriadou V; Atkar R; Batchelor J; McDonald B; Novakovic L; Patel JV; Ravenscroft J; Rush E; Shah D; Shah R; Shaw L; Thompson AR; Hashme M; Exton LS; Mohd Mustapa MF; Manounah L;
    Br J Dermatol; 2022 Jan; 186(1):18-29. PubMed ID: 34160061
    [No Abstract]   [Full Text] [Related]  

  • 5. Micropigmentation-A revived therapeutic tool for recalcitrant, difficult-to-treat periungual vitiligo.
    Sharma A; Agrawal S; Dhurat R; Mhatre M; Surve R; Kerure A
    Dermatol Ther; 2020 Jul; 33(4):e13568. PubMed ID: 32401406
    [No Abstract]   [Full Text] [Related]  

  • 6. Repigmentation of poliosis in a patient with segmental vitiligo.
    Bae JM; Kwon HS; Lee JH; Kim GM
    J Am Acad Dermatol; 2016 Jul; 75(1):e23-4. PubMed ID: 27317537
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential diagnosis of idiopathic vitiligo. Part III: Occupational leukoderma.
    Fisher AA
    Cutis; 1994 Jun; 53(6):278-80. PubMed ID: 8070279
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of noncultured melanocyte-keratinocyte cell suspension vs hair follicular cell suspension transfer in stable vitiligo: A randomized controlled trial.
    Moosavi Z; Miramin Mohammadi A; Tavakkoli K; Daniel VT; Variji Z; Javadi A; Feizi Konjini L; Firooz A
    Dermatol Ther; 2020 May; 33(3):e13309. PubMed ID: 32162392
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitiligo and leukoderma in children.
    Herane MI
    Clin Dermatol; 2003; 21(4):283-95. PubMed ID: 14572699
    [No Abstract]   [Full Text] [Related]  

  • 10. Special Considerations in Children with Vitiligo.
    Taïeb A; Seneschal J; Mazereeuw-Hautier J
    Dermatol Clin; 2017 Apr; 35(2):229-233. PubMed ID: 28317531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative pilot study of dipstick versus open-spray cryotherapy techniques as depigmentation treatments for vitiligo.
    Abdallah M; Saleh HM
    J Cosmet Dermatol; 2022 Apr; 21(4):1772-1773. PubMed ID: 34216083
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic options and hot topics in vitiligo with special focus on pediatrics' vitiligo: A comprehensive review study.
    Roohaninasab M; Mansouri P; Seirafianpour F; Naeini AJ; Goodarzi A
    Dermatol Ther; 2021 Jan; 34(1):e14550. PubMed ID: 33200859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitiligo or Vitiligo-like Hypopigmentation Associated with Imiquimod Treatment of Condyloma Acuminatum: Not a Casual Event.
    Long FQ; Zhao LS; Qian YH
    Chin Med J (Engl); 2017 Feb; 130(4):503-504. PubMed ID: 28218231
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features.
    Hartmann A; Bedenk C; Keikavoussi P; Becker JC; Hamm H; Bröcker EB
    J Dtsch Dermatol Ges; 2008 Dec; 6(12):1053-9. PubMed ID: 18479500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Double Strike Hypothesis of the vitiligo pathomechanism: new approaches to vitiligo and melanoma.
    Michelsen D
    Med Hypotheses; 2010 Jan; 74(1):67-70. PubMed ID: 19748188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo Impact Scale (VIS)-22: A measure of the psycho-social burden of vitiligo.
    Gupta V; Ramam M
    Indian J Dermatol Venereol Leprol; 2022; 88(5):691-695. PubMed ID: 35962518
    [No Abstract]   [Full Text] [Related]  

  • 17. A rational approach to the treatment of vitiligo and other hypomelanoses.
    Hercogová J; Buggiani G; Prignano F; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):383-92, ix. PubMed ID: 17662904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells.
    Boniface K; Seneschal J
    Exp Dermatol; 2019 Jun; 28(6):656-661. PubMed ID: 30636075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the minimal important change in the vitiligo extent score and the self-assessment vitiligo extent score.
    Uitentuis SE; Wolkerstorfer A; Bae JM; Esmat S; Mogawer RM; Ragab N; Chuah SY; Passeron T; van Geel N; Thng STG; Terwee CB; Bekkenk MW
    J Am Acad Dermatol; 2021 Nov; 85(5):1363-1364. PubMed ID: 33122021
    [No Abstract]   [Full Text] [Related]  

  • 20. Ultra-violet therapy in cases of leucoderma.
    MENON AN
    Ind Med Gaz; 1945 Dec; 80(12):612-4. PubMed ID: 21026566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.